In addition, the increase in beclin-1 serum levels was associated with severe inflammation in COVID-19 [21], and the suppression of autophagy in leukocytes of severely ill COVID-19 patients correlated with impaired antigen presentation and T cell activation [22]. This evidence concerns the gene BECN1 and COVID-19.